ZA200609890B - Injectable pharmaceutical suspension comprising posaconazole - Google Patents

Injectable pharmaceutical suspension comprising posaconazole

Info

Publication number
ZA200609890B
ZA200609890B ZA200609890A ZA200609890A ZA200609890B ZA 200609890 B ZA200609890 B ZA 200609890B ZA 200609890 A ZA200609890 A ZA 200609890A ZA 200609890 A ZA200609890 A ZA 200609890A ZA 200609890 B ZA200609890 B ZA 200609890B
Authority
ZA
South Africa
Prior art keywords
posaconazole
injectable pharmaceutical
pharmaceutical suspension
suspension
injectable
Prior art date
Application number
ZA200609890A
Other languages
English (en)
Inventor
Witchey-Lakshmanan Leonore
Ugwu Sydney
Sandweiss Varda
Hardalo Catherine
Roberta S Hare
Krishna Gopal
Wang Zaiqi
Taglietti Marco
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971355&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200609890(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA200609890B publication Critical patent/ZA200609890B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200609890A 2004-05-28 2006-11-27 Injectable pharmaceutical suspension comprising posaconazole ZA200609890B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57512604P 2004-05-28 2004-05-28

Publications (1)

Publication Number Publication Date
ZA200609890B true ZA200609890B (en) 2008-09-25

Family

ID=34971355

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200609890A ZA200609890B (en) 2004-05-28 2006-11-27 Injectable pharmaceutical suspension comprising posaconazole

Country Status (15)

Country Link
EP (1) EP1761247A1 (xx)
JP (1) JP2008501034A (xx)
KR (1) KR20070027564A (xx)
CN (1) CN1988887A (xx)
AR (1) AR049063A1 (xx)
AU (1) AU2005249502A1 (xx)
CA (1) CA2567803A1 (xx)
IL (1) IL179627A0 (xx)
MX (1) MXPA06013886A (xx)
NO (1) NO20066005L (xx)
PE (1) PE20060291A1 (xx)
RU (1) RU2006146555A (xx)
TW (1) TWI290051B (xx)
WO (1) WO2005117831A1 (xx)
ZA (1) ZA200609890B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
SI2018164T1 (sl) 2006-05-12 2017-07-31 Christian Noe Uporaba kombinacijskih pripravkov, ki obsegajo antimikotike
EP2130540A1 (en) * 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
EP2451805A1 (en) 2009-07-09 2012-05-16 Sandoz AG A crystalline form of posaconazole
AU2011254654B2 (en) 2010-05-19 2016-01-07 Sandoz Ag Process for the preparation of chiral triazolones
EP2571847B1 (en) 2010-05-19 2016-09-21 Sandoz AG Process for the preparation of chiral hydrazides
WO2011144657A1 (en) 2010-05-19 2011-11-24 Sandoz Ag Purification of posaconazole and posaconazole intermediates
CA2798007C (en) 2010-05-19 2018-10-23 Sandoz Ag Preparation of posaconazole intermediates
JP6008849B2 (ja) 2010-06-29 2016-10-19 メルク・シャープ・エンド・ドーム・コーポレイション 置換β−シクロデキストリンにより安定化されたポサコナゾール静脈注射用溶液製剤
WO2012172015A1 (en) 2011-06-16 2012-12-20 Sandoz Ag Process for the preparation of a chiral compound
CN103284959B (zh) * 2012-02-22 2015-06-03 重庆圣华曦药业股份有限公司 泊沙康唑冻干粉针剂及制备方法
CN102755628B (zh) * 2012-07-16 2013-10-23 中国科学院微生物研究所 一种抗真菌的药物组合物
CN102805731B (zh) * 2012-08-22 2014-04-30 北京莱瑞森医药科技有限公司 泊沙康唑干混悬剂及其制备方法
CN105030668B (zh) * 2015-06-26 2018-03-27 济川药业集团有限公司 泊沙康唑口服混悬剂及其制备方法
CN106333925B (zh) * 2015-07-10 2019-06-18 上海美悦生物科技发展有限公司 一种泊沙康唑液体混悬剂及其制备方法
CN105997872B (zh) * 2016-07-08 2019-02-19 河南省立眼科医院 一种含有泊沙康唑的眼用纳米胶束抗真菌溶液
MX2019011603A (es) * 2017-03-26 2021-08-16 Robyn Vivi Stafford Metodo de tratamiento de las condiciones de la piel de los parpados.
KR20200059188A (ko) * 2017-04-12 2020-05-28 비카쉬 제이. 바그완딘 내성 종양의 민감화를 위해 포사코나졸을 사용한 조성물, 패키징된 약제, 및 방법
CN110507609B (zh) * 2018-05-21 2021-09-17 上海医药工业研究院 泊沙康唑口服混悬剂的制备方法
CN111514146A (zh) * 2020-04-28 2020-08-11 山西振东泰盛制药有限公司 含有泊沙康唑的药物组合物
CN113933131B (zh) * 2021-09-24 2024-01-26 合肥天一生物技术研究所有限责任公司 一种阴道微生物荧光染色液

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
MXPA03009021A (es) * 2001-04-03 2004-02-12 Schering Corp Composicion antifungal con biodisponibilidad aumentada.

Also Published As

Publication number Publication date
KR20070027564A (ko) 2007-03-09
NO20066005L (no) 2007-02-27
JP2008501034A (ja) 2008-01-17
EP1761247A1 (en) 2007-03-14
PE20060291A1 (es) 2006-04-14
AR049063A1 (es) 2006-06-21
TWI290051B (en) 2007-11-21
RU2006146555A (ru) 2008-07-20
MXPA06013886A (es) 2007-01-26
CN1988887A (zh) 2007-06-27
TW200609001A (en) 2006-03-16
CA2567803A1 (en) 2005-12-15
WO2005117831A1 (en) 2005-12-15
IL179627A0 (en) 2007-05-15
AU2005249502A1 (en) 2005-12-15

Similar Documents

Publication Publication Date Title
ZA200609890B (en) Injectable pharmaceutical suspension comprising posaconazole
ZA200504239B (en) Pharmaceutical suspension composition
IL177480A0 (en) Pharmaceutical composition
PL1957073T3 (pl) Substancja lecznicza
GB0419849D0 (en) Pharmaceutical combination
HK1112427A1 (en) Drug delivery compositions and related methods
EP1778252A4 (en) NON-CARDIOTOXIC PHARMACEUTICAL COMPOUNDS
EP1714648A4 (en) COMBINATION DRUGS
EP1948138A4 (en) SEGMENTED PHARMACEUTICAL FORMS
ZA200803152B (en) Oramucosal pharmaceutical dosage form
EP1871344A4 (en) INHIBITABLE MEDICINAL PRODUCT
IL180487A0 (en) Medicament
HU0401177D0 (en) Pharmaceutical composition
GB2411355B (en) Pharmaceutical composition
ZA200701932B (en) Pharmaceutical composition
GB0425255D0 (en) Pharmaceutical composition
ZA200701931B (en) Pharmaceutical composition
TWI372053B (en) Combination drug
HUP0401176A2 (en) Pharmaceutical composition having prpkinetic effect
EP1934388A4 (en) METHOD FOR THE DEVELOPMENT OF MEDICAMENTS
PT1944298E (pt) Derivado de quinazolina e fármaco
EP1716865A4 (en) PHARMACEUTICAL PREPARATION CONTAINING PARAOXONASE
IL185561A0 (en) Microject devices and methods for drug delivery
GB0417777D0 (en) Pharmaceutical combination
GB0402799D0 (en) Pharmaceutical composition